WNT PATHWAY ACTIVATION IN HEPATOCELLULAR CARCINOMA - IDENTIFICATION OF THE WNT CO-ACTIVATOR PYGO2 AS A CANDIDATE ONCOGENE

被引:0
|
作者
Savic, Radoslav [1 ]
Newell, Philippa [1 ]
Villanueva, Augusto [2 ]
Toffanin, Sara [1 ,4 ]
Hoshida, Yujin [3 ]
Chiang, Derek Y. [3 ]
Cabellos, Laia [1 ]
Minguez, Beatriz [1 ]
Lachenmayer, Anja [1 ]
Cornella, Helena [2 ]
Tovar, Victoria [2 ]
Alsinet, Clara [2 ]
Peix, Judit [2 ]
Thung, Swan N. [1 ]
Roayaie, Sasan [1 ]
Schwartz, Myron E. [1 ]
Bruix, Jordi [2 ]
Mozzaferro, Vincenzo [4 ]
Friedman, Scott L. [1 ]
Llovet, Josep M. [1 ,2 ]
机构
[1] Mt Sinai Sch Med, Mt Sinai Liver Canc Program, Div Liver Dis, New York, NY USA
[2] Hosp Clin Barcelona, Liver Unit, HCC Translat Res Lab, CIBERehd,BCLC, Barcelona, Spain
[3] Broad Inst Harvard & MIT, Canc Program, Cambridge, MA USA
[4] Natl Canc Inst, Gastrointestinal Surg & Liver Transplantat Unit, I-20133 Milan, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1316
引用
收藏
页码:912A / 912A
页数:1
相关论文
共 50 条
  • [31] Alterations of β-catenin and Tcf-4 instead of GSK-3β contribute to activation of Wnt pathway in hepatocellular carcinoma
    Cui, J
    Zhou, XD
    Liu, YK
    Tang, ZY
    Romeih, M
    [J]. CHINESE MEDICAL JOURNAL, 2003, 116 (12) : 1885 - 1892
  • [32] Alterations of β-catenin and Tcf-4 instead of GSK-3β contribute to activation of Wnt pathway in hepatocellular carcinoma
    崔健
    周信达
    刘银坤
    汤钊猷
    Mahmoud Romeih
    [J]. ChineseMedicalJournal, 2003, (12)
  • [33] Alterations of β-catenin and Tcf-4 instead of GSK-3β contribute to activation of Wnt pathway in hepatocellular carcinoma
    崔健
    周信达
    刘银坤
    汤钊猷
    Mahmoud Romeih
    [J]. 中华医学杂志(英文版), 2003, (12) : 93 - 100
  • [34] Expression of Wnt11 and Rock2 in esophageal squamous cell carcinoma by activation of the WNT/PCP pathway and its clinical significance
    Wang, Xuefen
    Liu, Dong
    Zhou, Keming
    Wang, Bowei
    Liu, Qian
    Deng, Feiyan
    Li, Qiaoxin
    Ma, Yuqing
    [J]. PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (10) : 880 - 885
  • [35] Smad2 functions as a co-activator of canonical Wnt/β-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300
    Hirota, Morihisa
    Watanabe, Kazuhide
    Hamada, Shin
    Sun, Youping
    Strizzi, Luigi
    Mancino, Mario
    Nagaoka, Tadahiro
    Gonzales, Monica
    Seno, Masaharu
    Bianco, Caterina
    Salomon, David S.
    [J]. CELLULAR SIGNALLING, 2008, 20 (09) : 1632 - 1641
  • [36] Overexpression of p62/IMP2 can Promote Cell Migration in Hepatocellular Carcinoma via Activation of the Wnt/β-Catenin Pathway
    Xing, Mengtao
    Li, Pei
    Wang, Xiao
    Li, Jitian
    Shi, Jianxiang
    Qin, Jiejie
    Zhang, Xiaojun
    Ma, Yangcheng
    Francia, Giulio
    Zhang, Jian-Ying
    [J]. CANCERS, 2020, 12 (01)
  • [37] ASO Visual Abstract: Expression of Wnt5a and ROR2, Components of the Noncanonical Wnt Signaling Pathway, is Associated with Tumor Differentiation in Hepatocellular Carcinoma
    Wakizaka, Kazuki
    Kamiyama, Toshiya
    Kakisaka, Tatsuhiko
    Orimo, Tatsuya
    Nagatsu, Akihisa
    Aiyama, Takeshi
    Shichi, Shunsuke
    Taketomi, Akinobu
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (03) : 2131 - 2132
  • [38] R-spondin 2 promotes proliferation and migration via the Wnt/β-catenin pathway in human hepatocellular carcinoma
    Yin, Xinguang
    Yi, Huixing
    Wang, Linlin
    Wu, Wanxin
    Wu, Xiaojun
    Yu, Linghua
    [J]. ONCOLOGY LETTERS, 2017, 14 (02) : 1757 - 1765
  • [39] Activation of Wnt/β-catenin signalling pathway induces chemoresistance to interferon-α/5-fluorouracil combination therapy for hepatocellular carcinoma
    Noda, T.
    Nagano, H.
    Takemasa, I.
    Yoshioka, S.
    Murakami, M.
    Wada, H.
    Kobayashi, S.
    Marubashi, S.
    Takeda, Y.
    Dono, K.
    Umeshita, K.
    Matsuura, N.
    Matsubara, K.
    Doki, Y.
    Mori, M.
    Monden, M.
    [J]. BRITISH JOURNAL OF CANCER, 2009, 100 (10) : 1647 - 1658
  • [40] LNCRNA TLNC1 PROMOTES THE DEVELOPMENT AND PROGRESSION OF HEPATOCELLULAR CARCINOMA VIA ACTIVATION OF WNT/B-CATENIN PATHWAY
    Yuan, Kefei
    [J]. HEPATOLOGY, 2019, 70 : 113A - 114A